Carnival and WTTC to hold joint Covid-19 conference
Cruise Adviser
CRUISE NEWS, COMMENT, INTERVIEWS AND ANALYSIS FROM CRUISE ADVISER, THE LEADING CRUISE PUBLICATION FOR THE TRAVEL TRADE

Carnival and WTTC to hold joint Covid-19 conference

The World Travel & Tourism Council and Carnival Corporation are to hold a joint conference entitled Global Science Summit on Covid-19.

The free online event will be held on July 23 from 2pm until 5.30pm and will focus on the ‘new normal’ according to a release.

The Global Science Summit on Covid-19 will feature global tourism leaders, WTTC Members, government agencies, destination partners, trade and private businesses sharing the latest science and medical evidence that can be used to inform “practical, adaptable and science-based solutions”.

Gloria Guevara, WTTC president & CEO, said: “I was excited when Arnold, on behalf of Carnival Corporation, approached me with this idea. This event will be a powerful platform for harnessing the best thinking from across all fields of knowledge in the public and private sectors. The science of this virus is rapidly evolving and these real-time insights will be invaluable in helping us determine evidence-based protection and mitigation measures to combat COVID-19. They will also help drive global alignment and collaboration on the frontiers of science and policy, which is critical to the survival of this important sector.”

“COVID-19 has had a crushing global socio-economic impact and is threatening the jobs of millions of people whose very livelihoods depend upon a thriving Travel & Tourism sector for their survival.”

Arnold Donald, President & CEO of Carnival Corporation, is a member of the WTTC Executive Committee and its vice chair for North America.

“Our highest responsibility and top priorities are compliance, protecting the environment and the safety, health and well-being of our guests, our crew members and the people in the communities we visit,” said Donald. “Throughout the pause in our guest operations, we have been consulting and assembling the best minds in medical science, public health and infectious disease control. We are grateful to bring together a select group of science and medical experts who bring such relevant insight into COVID-19 for the public to hear. Hopefully, this Summit will be an efficient way for attendees to become more informed about COVID-19 in the space of just a few hours.”

Panels will include a mix of science-based debates and discussions sharing the latest thinking on the following key topic areas:

  • Epidemiology: Incubation and peak infectivity periods for SARS-CoV-2; disease progression from exposure to illness; and symptom variability among different individuals and groups.
  • Transmission: How, when and where SARS-CoV-2 spreads; significance of environmental transmission; guidelines for mitigating spread.
  • Screening and Testing:  Availability and accuracy of current testing methods; viable and cost effective ways to detect illness and effectiveness of screening using temperature and health questionnaires.
  • Therapeutics:  Status of vaccine development; available and approved SARS-CoV-2 treatment protocols; the role of cytokine storms; and profiles of COVID-19 recovery.
  • Practical Risk Mitigation:  Measures to mitigate the risks of social gatherings; balancing the benefits and risks of social gatherings; the role of testing, contact tracing, and managing the psychology of fear.

Registration Details

To register for the Summit, please go to CovidScienceSummit.com  Global participants will be invited to submit questions in advance and during the online event. Members of the media are welcome to join for all or part of the sessions or connect with members and/or presenters.

Comments are closed, but trackbacks and pingbacks are open.